Why remdesivir, a highly effective COVID treatment, is a last resort for providers
(By Pien Huang for NPR) In late December, as the omicron variant surged, the roster of early COVID-19 treatments was
Read More(By Pien Huang for NPR) In late December, as the omicron variant surged, the roster of early COVID-19 treatments was
Read More(By Nick Moran for Becker’s Hospital Review) CMS is seeking input on an Advanced Notice that includes proposed changes to
Read More(By Sydney Lupkin for NPR) The United States is spending about $530 for each 5-day course of Pfizer’s COVID-19 pill,
Read MoreMedicare Advantage Plans, sometimes called “Part C” or “MA Plans,” are offered by Medicare-approved private companies that must follow the
Read More(By Juliette Cubanski, Nolan Sroczynski , and Tricia Neuman for Kaiser Family Foundation published January 27, 2022) The Build Back
Read MoreOne of the decisions a Medicare-eligible individual needs to make is the type of health insurance for their retirement. You
Read More(By Joe Hernandez for NPR) Billionaire investor and Dallas Mavericks owner Mark Cuban has launched an online pharmacy for generic
Read More(By Liz Szabo for Kaiser Health News) Patients with weakened immune systems — who are at high risk from covid-19
Read MoreDid you miss your initial Medicare enrollment period? For those individuals who missed enrolling in Medicare when they were first
Read More(By Nick Moran for Becker’s Hospital Review) Following CMS’s preliminary decision to limit the coverage of Biogen’s Alzehimer’s disease treatment
Read More